167 related articles for article (PubMed ID: 19843683)
1. Selenium supplementation reduced oxidative DNA damage in adnexectomized BRCA1 mutations carriers.
Dziaman T; Huzarski T; Gackowski D; Rozalski R; Siomek A; Szpila A; Guz J; Lubinski J; Wasowicz W; Roszkowski K; Olinski R
Cancer Epidemiol Biomarkers Prev; 2009 Nov; 18(11):2923-8. PubMed ID: 19843683
[TBL] [Abstract][Full Text] [Related]
2. Increased rates of chromosome breakage in BRCA1 carriers are normalized by oral selenium supplementation.
Kowalska E; Narod SA; Huzarski T; Zajaczek S; Huzarska J; Gorski B; Lubinski J
Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1302-6. PubMed ID: 15894690
[TBL] [Abstract][Full Text] [Related]
3. Elevated level of 8-oxo-7,8-dihydro-2'-deoxyguanosine in leukocytes of BRCA1 mutation carriers compared to healthy controls.
Dziaman T; Huzarski T; Gackowski D; Rozalski R; Siomek A; Szpila A; Guz J; Lubinski J; Olinski R
Int J Cancer; 2009 Nov; 125(9):2209-13. PubMed ID: 19623658
[TBL] [Abstract][Full Text] [Related]
4. Induced micronucleus frequencies in peripheral lymphocytes as a screening test for carriers of a BRCA1 mutation in breast cancer families.
Rothfuss A; Schütz P; Bochum S; Volm T; Eberhardt E; Kreienberg R; Vogel W; Speit G
Cancer Res; 2000 Jan; 60(2):390-4. PubMed ID: 10667592
[TBL] [Abstract][Full Text] [Related]
5. Prospective study of 8-oxo-7,8-dihydro-2'-deoxyguanosine excretion and the risk of lung cancer.
Loft S; Svoboda P; Kasai H; Tjønneland A; Vogel U; Møller P; Overvad K; Raaschou-Nielsen O
Carcinogenesis; 2006 Jun; 27(6):1245-50. PubMed ID: 16364924
[TBL] [Abstract][Full Text] [Related]
6. Pathologic characteristics of breast parenchyma in patients with hereditary breast carcinoma, including BRCA1 and BRCA2 mutation carriers.
Adem C; Reynolds C; Soderberg CL; Slezak JM; McDonnell SK; Sebo TJ; Schaid DJ; Myers JL; Sellers TA; Hartmann LC; Jenkins RB
Cancer; 2003 Jan; 97(1):1-11. PubMed ID: 12491499
[TBL] [Abstract][Full Text] [Related]
7. Helicobacter pylori infection is associated with oxidatively damaged DNA in human leukocytes and decreased level of urinary 8-oxo-7,8-dihydroguanine.
Siomek A; Rytarowska A; Szaflarska-Poplawska A; Gackowski D; Rozalski R; Dziaman T; Czerwionka-Szaflarska M; Olinski R
Carcinogenesis; 2006 Mar; 27(3):405-8. PubMed ID: 16219635
[TBL] [Abstract][Full Text] [Related]
8. Skewed X chromosome inactivation and breast and ovarian cancer status: evidence for X-linked modifiers of BRCA1.
Lose F; Duffy DL; Kay GF; Kedda MA; Spurdle AB; ;
J Natl Cancer Inst; 2008 Nov; 100(21):1519-29. PubMed ID: 18957670
[TBL] [Abstract][Full Text] [Related]
9. A single nucleotide polymorphism in the 5' untranslated region of RAD51 and risk of cancer among BRCA1/2 mutation carriers.
Wang WW; Spurdle AB; Kolachana P; Bove B; Modan B; Ebbers SM; Suthers G; Tucker MA; Kaufman DJ; Doody MM; Tarone RE; Daly M; Levavi H; Pierce H; Chetrit A; Yechezkel GH; Chenevix-Trench G; Offit K; Godwin AK; Struewing JP
Cancer Epidemiol Biomarkers Prev; 2001 Sep; 10(9):955-60. PubMed ID: 11535547
[TBL] [Abstract][Full Text] [Related]
10. Effects of basal level of antioxidants on oxidative DNA damage in humans.
Foksinski M; Gackowski D; Rozalski R; Siomek A; Guz J; Szpila A; Dziaman T; Olinski R
Eur J Nutr; 2007 Apr; 46(3):174-80. PubMed ID: 17265170
[TBL] [Abstract][Full Text] [Related]
11. Biomarkers of oxidative damage to DNA and repair.
Loft S; Høgh Danielsen P; Mikkelsen L; Risom L; Forchhammer L; Møller P
Biochem Soc Trans; 2008 Oct; 36(Pt 5):1071-6. PubMed ID: 18793191
[TBL] [Abstract][Full Text] [Related]
12. Association between clinical characteristics and risk-reduction interventions in women who underwent BRCA1 and BRCA2 testing: a single-institution study.
Uyei A; Peterson SK; Erlichman J; Broglio K; Yekell S; Schmeler K; Lu K; Meric-Bernstam F; Amos C; Strong L; Arun B
Cancer; 2006 Dec; 107(12):2745-51. PubMed ID: 17109443
[TBL] [Abstract][Full Text] [Related]
13. Intra-abdominal carcinomatosis after prophylactic oophorectomy in women of hereditary breast ovarian cancer syndrome kindreds associated with BRCA1 and BRCA2 mutations.
Casey MJ; Synder C; Bewtra C; Narod SA; Watson P; Lynch HT
Gynecol Oncol; 2005 May; 97(2):457-67. PubMed ID: 15863145
[TBL] [Abstract][Full Text] [Related]
14. Breast cancer risk reduction associated with the RAD51 polymorphism among carriers of the BRCA1 5382insC mutation in Poland.
Jakubowska A; Narod SA; Goldgar DE; Mierzejewski M; Masojć B; Nej K; Huzarska J; Byrski T; Górski B; Lubiński J
Cancer Epidemiol Biomarkers Prev; 2003 May; 12(5):457-9. PubMed ID: 12750242
[TBL] [Abstract][Full Text] [Related]
15. The RAD51 135 G>C polymorphism modifies breast cancer and ovarian cancer risk in Polish BRCA1 mutation carriers.
Jakubowska A; Gronwald J; Menkiszak J; Górski B; Huzarski T; Byrski T; Edler L; Lubiñski J; Scott RJ; Hamann U
Cancer Epidemiol Biomarkers Prev; 2007 Feb; 16(2):270-5. PubMed ID: 17301259
[TBL] [Abstract][Full Text] [Related]
16. Basal, oxidative and alkylative DNA damage, DNA repair efficacy and mutagen sensitivity in breast cancer.
Blasiak J; Arabski M; Krupa R; Wozniak K; Rykala J; Kolacinska A; Morawiec Z; Drzewoski J; Zadrozny M
Mutat Res; 2004 Oct; 554(1-2):139-48. PubMed ID: 15450412
[TBL] [Abstract][Full Text] [Related]
17. High dietary intake of sodium selenite induces oxidative DNA damage in rat liver.
Wycherly BJ; Moak MA; Christensen MJ
Nutr Cancer; 2004; 48(1):78-83. PubMed ID: 15203381
[TBL] [Abstract][Full Text] [Related]
18. A BRCA1 mutation is not associated with increased indicators of oxidative stress.
Kotsopoulos J; Shen H; Rao AV; Poll A; Ainsworth P; Fleshner N; Narod SA
Clin Breast Cancer; 2008 Dec; 8(6):506-10. PubMed ID: 19073505
[TBL] [Abstract][Full Text] [Related]
19. Selenium and GPx-1 overexpression protect mammalian cells against UV-induced DNA damage.
Baliga MS; Wang H; Zhuo P; Schwartz JL; Diamond AM
Biol Trace Elem Res; 2007 Mar; 115(3):227-42. PubMed ID: 17625244
[TBL] [Abstract][Full Text] [Related]
20. Ovarian cancer risk in Ashkenazi Jewish carriers of BRCA1 and BRCA2 mutations.
Satagopan JM; Boyd J; Kauff ND; Robson M; Scheuer L; Narod S; Offit K
Clin Cancer Res; 2002 Dec; 8(12):3776-81. PubMed ID: 12473589
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
